Genomic Health

Genomic Health provides genomic information to personalize cancer treatment decisions. The company develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make treatment decisions. The company provides its tissue-based invasive breast, ductal carcinoma in situ (DCIS), prostate and colon Oncotype DX tests as clinical laboratory services, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a gene expression profile expressed as a single quantitative score. The company also provides an Oncotype DX test for patients with DCIS, a pre-invasive form of breast cancer.
  • TickerGHDX
  • ISINUS37244C1018
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

3 directors sold after exercising options/sold

Three Directors at Genomic Health Inc sold after exercising options/sold 37,060 shares at between 67.736USD and 69.011USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activi...

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

3 directors sold after exercising options/sold

Three Directors at Genomic Health Inc sold after exercising options/sold 37,060 shares at between 67.736USD and 69.011USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activi...

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

ValuEngine Rating and Forecast Report for GHDX

MarketLine Department

Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Laboratory Corporation of America Holdings since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organ...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch